Skip to main content

Table 2 Sample characteristics

From: Transitions of care interventions to improve quality of life among patients hospitalized with acute conditions: a systematic literature review

References Number of participants Age by study arm
[Mean (SD)]
Sex by study arm
[N (%) female]
Race/ethnicity by study arm
[N (%)]
Marital Status by study arm
[N (%) married]
Report of education levels Report of income levels Report of health insurance status Sub-group analysis of results by race/ethnicity
Abad-Corpa et al. [38] Total: 143
Treatment: 56
Control: 87
Treatment: 71.61 (8.37)
Control: 73.51 (7.77)
Treatment: 6 (10.7%)
Control: 7 (8%)
NR DS R PR NR NR
Aboumatar et al. [26] Total: 240
Treatment: 120
Control: 120
Treatment: 63.9 (9.6)
Control: 66 (10)
Treatment: 72 (60%)
Control: 76 (63.3%)
Treatment:
- White: 98 (81.6%)
- African American: 20 (16.7%)
- American Indian/Alaska Native: 2 (1.7%)
Control:
- White: 100 (83.3%)
- African American: 18 (15%)
- American Indian/Alaska Native: 2 (1.7%)
NR R R NR NR
Boter et al. [39] Total: 536 Treatment: 263
Control: 273
DS Treatment: 133 (51%)
Control: 143 (52%)
NR NR R NR NR NR
Chow et al. [32] Total: 85 Treatment: 43
Control: 42
Treatment: 54.5 (12.8)
Control: 59.4 (13.97)
Treatment: 18 (42.9%)
Control: 15 (34.9%)
NR Treatment: 28 (65.1%)
Control: 33 (78.6%)
R PR NR NR
Claiborne [28] Total: 28 Treatment: 16
Control: 12
Treatment: 70 (13.97)
Control: 65 (11.99)
Treatment: 9 (56.25%)
Control: 31 (23.5%)
Treatment:
- White: 12 (75%)
- African American: 4 (25%)
Control:
- White: 12 (100%)
Treatment: 13 (81.25%)
Control: 9 (75%)
R R R NR
Fjærtoft et al. [30] Total: 320 Treatment: 160
Control: 160
NR NR NR NR NR NR NR NR
Hanssen et al. [31] Total: 288 Treatment: 156
Control: 132
Treatment: 59.5 (12.9)
Control: 60.9 (10.8)
Treatment: 24 (15.4%)
Control: 31 (23.5%)
NR Treatment: 118 (75.6%)
Control: 107 (82.3%)
R NR NR NR
Harrison et al. [34] Total: 192 Treatment: 92
Control: 100
Treatment: 75.52 (10.41)
Control: 75.74 (9.40)
Treatment: 43 (47%)
Control: 44 (44%)
NR Treatment: 38 (41%)
Control: 43 (43%)
R NR NR NR
Hermiz et al. [40] Total: 177 Treatment: 84
Control: 93
DS Treatment: 43 (51.2%)
Control: 50 (53.8%)
NR NR NR NR NR NR
Konstam et al. [27] Total: 88 Treatment: 44
Control: 44
Treatment: 71.67 (11.98)
Control: 66.93 (13.10)
Treatment: 18 (40.9%)
Control: 14 (31.8%)
Treatment:
- Black: 4 (9.3%)
- Hispanic: 1 (2.3%)
- White: 38 (88.4%)
Control:
- Black: 4 (9.1%)
- Hispanic: 2 (4.5%)
- Native American: 1 (2.3%)
- White: 37 (84.1%)
NR NR NR NR NR
Mehralian et al. [36] Total: 110 Treatment: 55
Control: 55
Treatment: 61.28 (13)
Control: 62.7 (10)
DS NR Treatment: (100%)a
Control: (96%)a
NR NR NR NR
Rezapour-Nasrabad [37] Total: 168 Treatment: 83
Control: 85
DS Treatment: 31 (37.3%)
Control: 31 (36%)
NR Treatment: 67 (89.3%)
Control: 70 (95.9%)
R NR NR NR
Wells et al. [42] Total: 108 Treatment: 54
Control: 54
Treatment: 54.9 (12.23)
Control: 57.3 (8.66)
DS NR Treatment: 40 (74.1%)
Control: 38 (70.4%)
PR NR NR NR
Whitaker-Brown et al. [29] Total: 50 Treatment: 50
Control: 0
Treatment: 70.1 (11.7)
No control
Treatment: 21 (58%)
No control
Treatment:
- Caucasian: 30 (83%)
- African American: 6 (17%)
No control
Treatment: 18 (50%)
No control
NR NR NR NR
Wierzchowiecki et al. [41] Total: 160 Treatment: 80
Control: 80
Treatment: 67.3 (10.2)
Control: 69.5 (10.7)
Treatment: 32 (40%)
Control: 33 (41%)
NR NR NR NR NR NR
Wong et al. [33] Total: 108 Treatment: 54
Control: 54
Treatment: 67.5 (11.6)
Control: 71.5 (11.6)
Treatment: 34 (63%)
Control: 34 (63%)
NR Treatment: 37 (68.5%)
Control: 29 (53.7%)
PR NR NR NR
Woodend et al. [35] Total: 249 Treatment: 125
Control: 124
Heart Failure Group-Treatment 67 (13)
Control: 66 (11)
Angina Group-Treatment: 66 (12)
Control: 65 (10)
DS NR NR NR NR NR NR
  1. NR, not reported; DS, variable reported in different structure; R, reported; PR, proxy of variable reported
  2. aN not reported